Description
·
Conaz interferes with biosynthesis of triglycerides and
phopholipids by blocking fungal CYP450, thus altering cell membrane
permeability in susceptible fungi. It also inhibits other fungal enzymes
resulting in the accumulation of toxic concentrations of hydrogen peroxide.
·
Conaz, similarly to other azole antifungals, is a fungistatic
agent which causes growth arrest in fungal cells thereby preventing growth and
spread of the fungus throughout the body.